BD and Biosero collaborate to integrate robotic automation with flow cytometry technology, aiming to accelerate drug discovery.

Abhijeet Bhardwaj's commitment to technical excellence and innovation continues to drive successful outcomes in large-scale ...

Becton Dickinson & Co. closed 3.20% below its 52-week high of $248.42, which the company achieved on March 28th.

After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...

Invent.ai is working with Alo Yoga, a luxury activewear brand, to transform the retailers inventory planning and ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of ...

Becton, Dickinson and Company and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, announced a ...

ROCKVILLE, MD, UNITED STATES, January 23, 2025 /EINPresswire / -- The global cell culture media market is estimated at US$ 3.51 billion in 2024 and is projected to expand at a CAGR of 7.1% from 2024 ...

Telehealth and Telecare News since 2005 ...

Shares of Becton Dickinson & Co. BDX shed 1.02% to $237.92 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.61% to 6,086 ...

Medi-Vantage founder and President Maria Shepherd — who's also a MedExecWomen co-founder — says DeviceTalks Boston is a ...

Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device maker said on Tuesday, months after longtime CEO and founder Joe Kiani was ousted in a bitter proxy battle with ...